DK1339864T3 - Fremgangsmåde til fremstilling af piperidinderivater med mikroorganismer - Google Patents

Fremgangsmåde til fremstilling af piperidinderivater med mikroorganismer

Info

Publication number
DK1339864T3
DK1339864T3 DK01273746T DK01273746T DK1339864T3 DK 1339864 T3 DK1339864 T3 DK 1339864T3 DK 01273746 T DK01273746 T DK 01273746T DK 01273746 T DK01273746 T DK 01273746T DK 1339864 T3 DK1339864 T3 DK 1339864T3
Authority
DK
Denmark
Prior art keywords
streptomyces
microorganism
structure according
formulae
microorganisms
Prior art date
Application number
DK01273746T
Other languages
Danish (da)
English (en)
Inventor
Peter C Michels
Eric L Zirbes
Original Assignee
Amr Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amr Technology Inc filed Critical Amr Technology Inc
Application granted granted Critical
Publication of DK1339864T3 publication Critical patent/DK1339864T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01273746T 2000-11-08 2001-11-06 Fremgangsmåde til fremstilling af piperidinderivater med mikroorganismer DK1339864T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70895900A 2000-11-08 2000-11-08
US09/754,786 US6613907B2 (en) 2000-11-08 2001-01-04 Process for the production of piperidine derivatives with microorganisms
PCT/US2001/043714 WO2002083062A2 (en) 2000-11-08 2001-11-06 Process for the production of piperidine derivatives with microorganisms

Publications (1)

Publication Number Publication Date
DK1339864T3 true DK1339864T3 (da) 2009-04-14

Family

ID=24847879

Family Applications (2)

Application Number Title Priority Date Filing Date
DK01273746T DK1339864T3 (da) 2000-11-08 2001-11-06 Fremgangsmåde til fremstilling af piperidinderivater med mikroorganismer
DK08005953.8T DK1958935T3 (da) 2000-11-08 2001-11-06 Fremgangsmåde til fremstilling af terfenadin- og carebastinderivater med mikroorganismer

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK08005953.8T DK1958935T3 (da) 2000-11-08 2001-11-06 Fremgangsmåde til fremstilling af terfenadin- og carebastinderivater med mikroorganismer

Country Status (18)

Country Link
US (3) US6613907B2 (hu)
EP (2) EP1958935B1 (hu)
JP (3) JP4686112B2 (hu)
KR (1) KR100886727B1 (hu)
AT (2) ATE419257T1 (hu)
BR (1) BR0115191A (hu)
CA (1) CA2427387C (hu)
CY (2) CY1110595T1 (hu)
DE (1) DE60137255D1 (hu)
DK (2) DK1339864T3 (hu)
ES (2) ES2321805T3 (hu)
HU (1) HU230069B1 (hu)
MX (1) MXPA03004003A (hu)
NO (1) NO334436B1 (hu)
NZ (1) NZ526040A (hu)
PT (2) PT1339864E (hu)
RU (1) RU2290443C2 (hu)
WO (1) WO2002083062A2 (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613907B2 (en) * 2000-11-08 2003-09-02 Amr Technology, Inc. Process for the production of piperidine derivatives with microorganisms
WO2003032907A2 (en) * 2001-10-16 2003-04-24 Rxkinetix, Inc. High-concentration protein formulations and method of manufacture
WO2005016912A1 (en) * 2003-08-19 2005-02-24 Pfizer Inc. An efficient microbial preparation of capravirine metabolites m4 and m5
WO2009058943A1 (en) * 2007-10-31 2009-05-07 Montana State University Gliocladium isolate c-13 and methods of its use for producing volatile compounds and hydrocarbons
EP2105134A1 (en) 2008-03-24 2009-09-30 Ranbaxy Laboratories Limited Stable amorphous fexofenadine hydrochloride
EP2576761B1 (en) * 2010-06-03 2017-02-08 Carmel-Haifa University Economic Corporation Ltd Extracts of cyathus striatus mushrooms, pharmaceutical compositions comprising them and a new cyathus striatus strain
KR101987639B1 (ko) * 2017-05-11 2019-06-12 코스맥스 주식회사 신규 후시디움 코씨네움 균주 및 그 균주 배양액을 포함하는 피부미용 개선용 조성물
GB201807815D0 (en) 2018-05-14 2018-06-27 Hypha Discovery Ltd Hydroxylation techniques
GB201819209D0 (en) 2018-11-26 2019-01-09 Hypha Discovery Ltd Biocatalytic techniques
CN116496205A (zh) * 2022-05-06 2023-07-28 成都施贝康生物医药科技有限公司 一种卡瑞斯汀的盐及其用途

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3419469A (en) * 1965-12-08 1968-12-31 Sun Oil Co Production of carboxylic acids by microbiological oxidation of hydrocarbons
GB1242169A (en) 1969-04-09 1971-08-11 Ucb Sa Piperidine derivatives
US3649453A (en) * 1970-01-21 1972-03-14 Upjohn Co Process for microbiologically oxygenating 1-amidoadamantanes
US3878217A (en) 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
BE794598A (fr) 1972-01-28 1973-05-16 Richardson Merrell Inc Nouveaux derives olefiniques de piperidines substituees en 4 et leur procede de preparation
BE794596A (fr) 1972-01-28 1973-05-16 Richardson Merrell Inc Piperidinoalcanone-oximes substituees et leur procede de preparation
US3806526A (en) 1972-01-28 1974-04-23 Richardson Merrell Inc 1-aroylalkyl-4-diphenylmethyl piperidines
US3965257A (en) 1972-01-28 1976-06-22 Richardson-Merrell Inc. Compositions and methods for the treatment of the symptoms of histamine induced allergic reactions
DE2360091A1 (de) * 1972-12-06 1974-07-04 Erap Verfahren zur herstellung von zitronensaeure durch fermentation
US3941795A (en) 1974-02-08 1976-03-02 Richardson-Merrell Inc. α-ARYL-4-SUBSTITUTED PIPERIDINOALKANOL DERIVATIVES
US3931197A (en) 1974-02-08 1976-01-06 Richardson-Merrell Inc. Substituted piperidine derivatives
US3946022A (en) 1974-03-04 1976-03-23 Richardson-Merrell Inc. Piperidine derivatives
US3922276A (en) 1974-12-11 1975-11-25 Robins Co Inc A H 1-Substituted-4-benzylidenepiperidines
US3956296A (en) 1974-12-11 1976-05-11 A. H. Robins Company, Incorporated 1-Substituted-4-benzylpiperidines
US4254129A (en) 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4285958A (en) 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkylene ketones, pharmaceutical compositions thereof and method of use thereof
US4285957A (en) 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
US4254130A (en) 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4564594A (en) * 1983-06-30 1986-01-14 E. I. Du Pont De Nemours And Company Fermentation process for production of carboxylic acids
GB8321157D0 (en) 1983-08-05 1983-09-07 Fordonal Sa Piperidine derivatives
US4742175A (en) 1986-05-07 1988-05-03 Merrell Dow Pharmaceuticals Inc. Preparation of polymorphically pure terfenadine
NL8603073A (nl) * 1986-12-02 1988-07-01 Rijksuniversiteit Werkwijze voor het bereiden van polyesters door fermentatie; werkwijze voor het bereiden van optisch actieve carbonzuren en esters; polyester omvattende voortbrengselen.
US5032513A (en) * 1988-06-01 1991-07-16 Basf Corporation Process for the preparation of gamma and delta lactones
DE4034218A1 (de) * 1990-10-27 1992-04-30 Merck Patent Gmbh Verfahren zur herstellung von carebastin
EP1214937B1 (en) 1992-08-03 2007-05-30 Sepracor Inc. Terfenadine carboxylate and the treatment of dermal irritation
GB9312669D0 (en) 1993-06-18 1993-08-04 Orion Yhtymae Oy New opticla isomers
EP1026147B1 (en) 1993-06-24 2003-11-19 Albany Molecular Research, Inc. Compounds useful as intermediates in the production of piperidine derivatives
CN1168717C (zh) 1993-06-25 2004-09-29 默里尔药物公司 用于制备抗组胺哌啶衍生物的新中间体
ES2216191T3 (es) * 1997-03-11 2004-10-16 Aventis Pharmaceuticals Inc. Procedimiento para preparar acido 4-(4-(hidroxidifenil)-1-piperidinil)-1-hidroxibutil)-alfa,alfa-dimetilfenilacetico y derivados fosforilados.
FR2776302B1 (fr) 1998-03-19 2002-04-12 Hoechst Marion Roussel Inc Nouveau procede de preparation de la fexofenadine
US6613907B2 (en) 2000-11-08 2003-09-02 Amr Technology, Inc. Process for the production of piperidine derivatives with microorganisms

Also Published As

Publication number Publication date
EP1339864A2 (en) 2003-09-03
ATE419257T1 (de) 2009-01-15
NO334436B1 (no) 2014-03-03
US20020087003A1 (en) 2002-07-04
DK1958935T3 (da) 2011-10-03
NO20031974D0 (no) 2003-04-30
RU2003117021A (ru) 2005-01-20
PT1958935E (pt) 2011-08-17
US20050038254A1 (en) 2005-02-17
JP4966276B2 (ja) 2012-07-04
EP1339864B1 (en) 2008-12-31
JP4842215B2 (ja) 2011-12-21
WO2002083062A2 (en) 2002-10-24
ES2321805T3 (es) 2009-06-12
PT1339864E (pt) 2009-03-26
JP2007306927A (ja) 2007-11-29
US20070134774A1 (en) 2007-06-14
RU2290443C2 (ru) 2006-12-27
KR20030045168A (ko) 2003-06-09
EP1958935B1 (en) 2011-06-22
US6613907B2 (en) 2003-09-02
HU230069B1 (hu) 2015-06-29
WO2002083062A3 (en) 2003-01-03
EP1958935A3 (en) 2008-09-03
KR100886727B1 (ko) 2009-03-04
US7691615B2 (en) 2010-04-06
NO20031974L (no) 2003-06-13
ES2395243T3 (es) 2013-02-11
CY1110595T1 (el) 2015-04-29
JP2008295464A (ja) 2008-12-11
JP4686112B2 (ja) 2011-05-18
US7232908B2 (en) 2007-06-19
NZ526040A (en) 2005-10-28
CY1112344T1 (el) 2015-12-09
ATE513812T1 (de) 2011-07-15
EP1958935A2 (en) 2008-08-20
EP1339864A4 (en) 2005-01-12
BR0115191A (pt) 2004-12-14
MXPA03004003A (es) 2004-02-12
HUP0301652A3 (en) 2012-09-28
HUP0301652A2 (hu) 2003-10-28
CA2427387A1 (en) 2002-10-24
CA2427387C (en) 2012-01-31
JP2004522454A (ja) 2004-07-29
DE60137255D1 (de) 2009-02-12

Similar Documents

Publication Publication Date Title
CY1112344T1 (el) Μεθοδος για την παραγωγη παραγωγων τερφεναδινης και καρεβαστινης με μικροοργανισμους
ATE121091T1 (de) Phospholipase a2-inhibitor, mikroorganismen, die diesen inhibitor erzeugen und mehrere verfahren zu seiner herstellung.
WO2000047758A3 (en) Methods of making compounds
KR960014352A (ko) 탁산 제조시 중간체로서 유용한 화합물의 에난티오머 혼합물의 효소적 분할 방법
NZ599437A (en) Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives.
AU3274997A (en) Intermediates for the preparation of duocarmycin sa and derivatives thereof, and process for the production of the intermediates
JP2769194B2 (ja) 酵素分解方法
CA2023856A1 (en) Enzymatic resolution process
FR2385798A1 (fr) Procede de production de maytansinol et de ses derives par voie microbiologique
CA2399819A1 (en) Process for the enzymatic cleavage of racemates of aminomethyl-aryl-cyclohexanol derivatives
HUP9801621A2 (hu) Új eszteráz és eljárás optikailag aktív chromanvegyületek előállítására
WO2004111259A3 (en) Hydrolytic substrates for an analyte-dependent enzyme activation system
HU212279B (en) Process for preparing (+)-homopilopic acid
KR900000481A (ko) 3-메르캡토-2-알킬-프로피온산의 라세미 에스테르 유도체들의 광학 이성질체의 효소 분리방법
KR890003955A (ko) 광학 활성 인-함유 작용성 아세트산 유도체의 효소적 제조방밥
EP0264429A1 (en) ENZYMATIC PROCESS FOR PREPARING OPTICALLY-ACTIVE 1,2-DIHYDRO-3H-PYRROLO 1,2a]PYRROLE-1-CARBOXYLIC ACID DERIVATIVES
AU2001282002A1 (en) Method for the enantioselective reduction of 8-chloro-6-oxo-octanoic acid alkyl esters
US5476965A (en) Enzymatic resolution of substituted 2-methyl-propionic acid
ATE58142T1 (de) Valiolaminderivate und ihre herstellung.
DK0383248T3 (da) Fremgangsmåde til fremstilling af mevalonsyre
RU2001105315A (ru) Микробиологический способ получения оптически активных 3-гидроксипирролидиновых производных
WO2002022849A3 (en) Enzymatic resolution of aryl- and thio-substituted acids
EP1359145A4 (en) PROCESS FOR THE PREPARATION OF BENZYLPIPERIDINE COMPOUNDS
EP0148272A1 (en) Process for producing optically active benzyl alcohol compounds
ATE78057T1 (de) Mikrobische herstellung von brenzkatechinen.